Promised Land for Biotechnology
This article was originally published in Start Up
Israel is the hottest single country for high-tech start-ups in general, but advocates of life sciences say that additional funding specifically for biotechnology is needed. Without a strong pharmaceutical industry, Israel lacks the infrastructure necessary to nurture start-ups, for example, experienced executives to run companies.
You may also be interested in...
CellStain Technologies believes it has created a staining technique that emphasizes only malignant cells in a diagnostic sample, promising to take some of the subjectivity out of cancer screening.
Sol-Gel Technologies' manufacturing process for the encapsulation of bioactive molecules in a bioactive glass under gentle manufacturing conditions has many applications in health care.
Proneuron will develop new cell therapies and treatments for neurological disorders such as multiple sclerosis, Parkinson's diseases and Alzheimer's disease, ophthalmological disorders including anterior ischemic optic neuropathy and glaucoma, and immune disorders.